|
Post by liane on Feb 3, 2016 16:53:34 GMT -5
Shoutbox is turned on and can be viewed at the bottom of each page. Remember, nothing is permanent here. Please try to stay on topic and pertinent.
|
|
|
Post by uvula on Feb 3, 2016 16:55:13 GMT -5
Matt, for god's sake, please assume all microphones are turned on.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 3, 2016 16:58:37 GMT -5
Matt, for god's sake, please assume all microphones are turned on. Wouldnt you rather they are on to hear something we wouldnt normally hear?
|
|
|
Post by centralcoastinvestor on Feb 3, 2016 17:11:01 GMT -5
Afrezza will be co-promoted no matter who the new partners are in the future. I like that.
|
|
|
Shoutbox
Feb 3, 2016 17:11:50 GMT -5
via mobile
Post by uvula on Feb 3, 2016 17:11:50 GMT -5
I just saw an afrezza ad on the AdChoice box in the "related topics and stories" section of mnkd Proboards!
|
|
|
Shoutbox
Feb 3, 2016 17:26:12 GMT -5
via mobile
Post by boytroy88 on Feb 3, 2016 17:26:12 GMT -5
SP dropped to 0.86 ah...
|
|
|
Shoutbox
Feb 3, 2016 17:28:34 GMT -5
via mobile
Post by boytroy88 on Feb 3, 2016 17:28:34 GMT -5
Is it over already?
|
|
|
Post by centralcoastinvestor on Feb 3, 2016 17:49:09 GMT -5
The Goldman's analyst took every opportunity in his questions to mention bankruptcy. But he doesn't have an agenda.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 3, 2016 17:51:01 GMT -5
The Goldman's analyst took every opportunity in his questions to mention bankruptcy. But he doesn't have an agenda. The stock price was already down 12% before that questioned occured
|
|
|
Post by centralcoastinvestor on Feb 3, 2016 17:53:22 GMT -5
The Goldman's analyst took every opportunity in his questions to mention bankruptcy. But he doesn't have an agenda. The stock price was already down 12% before that questioned occured I think people are always hoping for big news and were disappointed that there was nothing new.
|
|
|
Post by bioexec25 on Feb 3, 2016 17:55:40 GMT -5
The Goldman's analyst took every opportunity in his questions to mention bankruptcy. But he doesn't have an agenda. Definitely an agenda in GSCO case. But in parallel, I believe some financial analysts with no agenda believe recovery is now less probable than BK given the huge task at hand with limited resources including a penny sp. But they don't figure any deals much in that prediction because they don't exist until they do.
|
|
|
Post by rch51 on Feb 3, 2016 18:00:50 GMT -5
Matt kept his word. Better communication and transparency is evident. Sadly no news that's going to move the needle. In fact, I suspect that the bears will find enough negative to drive pps down for awhile. Others I'm sure will have more to say - here's a few highlights:
Working with SEC to investigate blatant trading abuses! They (both) are aware and engaged actively. MNKD owns and controls a very significant patent portfolio (more than a thousand!)- actually it's HUGE! God knows what the patents are worth alone. Afrezza will include co-promotion with a partner but will retain all ownership rights to Afrezza No buyouts on the horizon Bankruptcy is not an option "at this time" - it's absolutely a last resort and not even on the radar No good indication of secured financial stability beyond 6 months or so - troubling FDA regulations are hamstringing the company (my words, not his) with respect to what can and cannot be said and used in marketing of Afrezza No time line provided for Intl marketing but it sounds like talks are ongoing in countries that would accept FDA approvals and require little or no addl trials Very impressive TS pipeline strategy with three solid candidates in early development stages. Looking for partners for each of their three early drug programs.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 3, 2016 18:01:37 GMT -5
The Goldman's analyst took every opportunity in his questions to mention bankruptcy. But he doesn't have an agenda. Definitely an agenda in GSCO case. But in parallel, I believe some financial analysts with no agenda believe recovery is now less probable than BK given the huge task at hand with limited resources including a penny sp. But they don't figure any deals much in that prediction because they don't exist until they do. Corey will be downgrading the stock to pennies in the near future. He seemed annoyed. I know nothing of Bio except for this stock or how the industry works so I dont know if the secreacy is common. INvesting in MNKD is purely faith based at this point IMO
|
|
|
Post by mindovermatter on Feb 3, 2016 18:08:48 GMT -5
Matt kept his word. Better communication and transparency is evident. Sadly no news that's going to move the needle. In fact, I suspect that the bears will find enough negative to drive pps down for awhile. Others I'm sure will have more to say - here's a few highlights: Working with SEC to investigate blatant trading abuses! They (both) are aware and engaged actively. MNKD owns and controls a very significant patent portfolio (more than a thousand!)- actually it's HUGE! God knows what the patents are worth alone. Afrezza will include co-promotion with a partner but will retain all ownership rights to Afrezza No buyouts on the horizon Bankruptcy is not an option "at this time" - it's absolutely a last resort and not even on the radar No good indication of secured financial stability beyond 6 months or so - troubling FDA regulations are hamstringing the company (my words, not his) with respect to what can and cannot be said and used in marketing of Afrezza No time line provided for Intl marketing but it sounds like talks are ongoing in countries that would accept FDA approvals and require little or no addl trials Very impressive TS pipeline strategy with three solid candidates in early development stages. Looking for partners for each of their three early drug programs. Sorry but patents are worthless if you do not have a product employing them that is selling. Case in point. Exubera.
|
|
|
Post by bioexec25 on Feb 3, 2016 18:10:08 GMT -5
Rev, with Bio and especially with disruptive technology it can be a little secret, but having said that, I personally have never seen a company so secret as Mnkd, but the more we learn about the Sny deal, it sounds like they absolutely have a stranglehold on things, more than I thought.
What I hate, is Apr 5th and they ask for more time. Great about the time the money begins to run out (absent a deal), we get control back. Wonderful. Sure am counting on a very sweet goodbye kiss from Sny, but they do not play nice so not holding out much hope for that.
|
|